Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
PaperCitations, authors & open-access status
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 344 citations, 2018 year and bronze oa status.
344
Citations
2018
Year
bronze
OA Status